What Is the Canakinumab Market? The Canakinumab Market refers to the global market for canakinumab-based therapies, a monoclonal antibody treatment designed to target interleukin-1 beta (IL-1β), a key protein involved in inflammatory responses. The market is expanding due to increasing adoption of advanced biologic therapies for rare inflammatory disorders, cardiovascular inflammation, and...